Equities

Guizhou Yibai Pharmaceutical Co Ltd

600594:SHH

Guizhou Yibai Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)3.09
  • Today's Change0.00 / 0.00%
  • Shares traded9.63m
  • 1 Year change-45.21%
  • Beta1.0458
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects GuiZhou YiBai Pharmaceutical Co., Ltd. share price to rise to 22.00 in the next year from the last price of 3.09.
High612.0%22.00
Med612.0%22.00
Low612.0%22.00

Dividends

Dividend information is not available for Guizhou Yibai Pharmaceutical Co Ltd.
Div growth (TTM)--
More ▼

Earnings history & estimates in CNY

On Apr 27, 2020, GuiZhou YiBai Pharmaceutical Co., Ltd. reported 4th quarter 2019 losses of -0.019 per share.
Average growth rate-0.11%
GuiZhou YiBai Pharmaceutical Co., Ltd. reported annual 2019 earnings of 0.179 per share on Apr 27, 2020.
Average growth rate+51.98%
More ▼

Revenue history & estimates in CNY

Revenue forecasts are not available for Guizhou Yibai Pharmaceutical Co., Ltd..
Average growth rate-1.76%
Annual revenue information is not available for Guizhou Yibai Pharmaceutical Co., Ltd..
Average growth rate+5.63%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.